What We Do
Investinor AS is an investment company. Together with enterprise founders, entrepreneurs and other investors, we turn selected promising companies into world-leading businesses.
Total assets ~NOK 8 billion
Investments in >70 portfolio companies
Investments in >45 funds and asset managers
>60 Co-investors in our portfolio
Total investments of ~NOK 27 billion together with partners
Responsible for 1/3 of all VC investments in Norway during the last 10 years
Dele Health raises NOK 65 million
(Oslo, December 28, 2020) Investinor, Gunnar Evensen, the Urbanski family, Altitude Capital and MP Pensjon are among the shareholders taking part in Dele Health Tech’s issuance of shares worth NOK 65 million. The company has a unique technology for reporting on and predicting falls among seniors in assisted living facilities, and now the US market will be conquered.
Cimon Medical is raising 60 MNOK to commercialize disruptive ultrasound technology
(Trondheim, December 12th, 2020) ProVenture and Investinor are taking the lead as the Norwegian ultrasound company Cimon Medical AS raises a total of MNOK 60 in capital. Cimon Medical provides unique technology for continuous measurement of blood flow. The technology has been developed by world leading ultrasound researchers, located in Trondheim. The target group for the company’s first product is premature and critically ill children.
Two of Investinor’s companies listed on Euronext Growth Oslo this Friday
Cyviz and Skitude will be listed on Euronext Growth Oslo (formerly Merkur Market) on Friday 18 December. Investinor has been the shareholder in both companies since 2014 and 2016, respectively, and had a great contribution to the processes of listing the companies.
Skitude seeks listing on Euronext Growth
Skitude Holding, in which Investinor has been a shareholder since 2016, is seeking listing on Euronext Growth Oslo. The company is planning to carry out a share issue of up to NOK 270 million in which Investinor is one of the anchor investors, together with Handelsbanken Fonder, Canica and the Andenæs Group.
Investinor with record financial gain in Calliditas Therapeutics
(Trondheim, 10.11.2020) Investinor AS (“Investinor”) has sold the majority of its shares in Calliditas Therapeutics AB (“Calliditas”), a publicly listed biotech company. Investinor’s financial gain in connection with its investment in Calliditas is more than NOK 475 million – the largest financial gain so far for Investinor.